261 related articles for article (PubMed ID: 32412771)
1. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
Guan X; Guan Y
Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
[TBL] [Abstract][Full Text] [Related]
2. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
3. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.
Wang J; Zeng H; Li H; Chen T; Wang L; Zhang K; Chen J; Wang R; Li Q; Wang S
Cell Physiol Biochem; 2017; 43(2):717-732. PubMed ID: 28946143
[TBL] [Abstract][Full Text] [Related]
5. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
7. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
Kong Z; Han Q; Zhu B; Wan L; Feng E
Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
[TBL] [Abstract][Full Text] [Related]
8. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
[TBL] [Abstract][Full Text] [Related]
12. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.
Liu K; Xie F; Gao A; Zhang R; Zhang L; Xiao Z; Hu Q; Huang W; Huang Q; Lin B; Zhu J; Wang H; Que J; Lan X
Mol Cancer; 2017 Mar; 16(1):62. PubMed ID: 28288641
[TBL] [Abstract][Full Text] [Related]
13. miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin.
Du Q; Yuan Z; Huang X; Huang Y; Zhang J; Li R
Anticancer Drugs; 2022 Mar; 33(3):308-319. PubMed ID: 34924500
[TBL] [Abstract][Full Text] [Related]
14. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
Zhang H; Xu W
Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
[TBL] [Abstract][Full Text] [Related]
15. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
16. miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2.
Tang W; Zhang X; Tan W; Gao J; Pan L; Ye X; Chen L; Zheng W
J Surg Res; 2019 Apr; 236():278-287. PubMed ID: 30694767
[TBL] [Abstract][Full Text] [Related]
17. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8.
Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H
Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
Yuan JH; Li WX; Hu C; Zhang B
Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
